Skip to main content

Seqens expands in solvents

Seqens plans to add a second production plant for isopropanol at the Roussillon chemical platform in southern France (pictured). This will have capacity of 50,000 tonnes/year, increasing the company’s total by 70%, and is due to start up in 2021. It will enjoy an optimised production and competitive access to raw materials and energy on site, the company said.

Oxea triples n-propanol production

Oxea, the world’s largest producer of n-propanol, has announced that it tripled its delivery volumes of n-propanol in Europe. This reflects very high demand from manufacturers of hand sanitisers in the Covid-19 crisis. The company claimed that certain studies show it to be more effective against viruses and bacteria at lower concentrations than other alcohols like ethanol and isopropanol.

Special Features - Covid-19: Regulatory issues for hand sanitiser

Anita Lloyd and Nicola Smith, directors in the Environmental, Safety & Health Group of Squire Patton Boggs, look at the key issues for companies starting to manufacture or import hand sanitiser

Many companies are looking at modifying their production lines and/or utilising spare capacity to manufacture hand sanitiser, which is in short supply due to the Covid-19 pandemic. Others may be looking into importing this product into the UK for the first time.

Feature Article – Covid-19 update: How the industry is responding

The news is entirely dominated by the coronavirus pandemic. Here, we summaries some of the key developments in the fine and speciality chemicals industry so far in April

Multiple companies are turning spare capacity over or building new capacity to supply hand sanitiser. Leading the way is Ineos, which had already built three such plants in the UK, France and Germany and has now announced plans to build a fourth at Etian, France, to serve hospitals in Paris, north-eastern France and Belgium.

AGC expands Spanish site

AGC has announced plans to expand its CDMO subsidiary, AGC Pharma Chemicals Europe. As well as adding 30% to the capacity of its production facilities by May 2022, this will see the addition of a new micronisation facility and a new R&D facility, which is due to begin operation in March 2021. The plant, near Barcelona, was originally known as Malgrat Pharma Chemicals.

Exclusive negotiations for Schülke & Mayr sale

Air Liquide has entered into exclusive negotiations with EQT, a differentiated global investment firm with over €62 billion in raise capital, for the sale of its Schülke & Mayr subsidiary. The company had announced its intention to sell Schülke & Mayr in November 2019 as part of a strategy of focusing on its core gases and healthcare businesses.

Round one to DuPont over Chemours in legal battle

The first step in ongoing litigation in the US between Chemours and its parent firm DuPont over the cost of environmental liabilities relating to historic pollution caused by per- and polyfluoroalkyl substances (PFASs) went DuPont’s way on 2 April. Chemours has said that it will appeal to the Delaware Supreme Court.

Subscribe to Current issue

 

 

 

AMRI banner advert